about
The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulationDoes insulin resistance drive the association between hyperglycemia and cardiovascular risk?The birth weight lowering C-allele of rs900400 near LEKR1 and CCNL1 associates with elevated insulin release following an oral glucose challengeEstimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes.Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults.Do gene variants influencing adult adiposity affect birth weight? A population-based study of 24 loci in 4,744 Danish individuals.Hepatic glucose sensing is impaired, but can be normalized, in people with impaired fasting glucose.Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescenceCognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional studyBisphenol A impairs hepatic glucose sensing in C57BL/6 male mice.Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort studyIncreased serum concentrations of persistent organic pollutants among prediabetic individuals: potential role of altered substrate oxidation patterns.Glucose patterns during the OGTT and risk of future diabetes in an urban Indian population: The CARRS study.Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs.Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans.Approaching pre-diabetes.Cardiovascular risk stratification and management in pre-diabetes.Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002-2010).Physical Activity Dimensions Associated with Impaired Glucose Metabolism.Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial).Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?Physical activity energy expenditure vs cardiorespiratory fitness level in impaired glucose metabolism.Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study.Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance.Association of self-perceived body image with body mass index and type 2 diabetes-The ADDITION-PRO study.Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study.Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610.Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis.Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes.Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study.Is it possible to develop a 'one-size fits all' prediction model for undiagnosed Type 2 diabetes?Impact of size at birth and prematurity on adult anthropometry in 4744 middle-aged Danes - The Inter99 study.Eighteen year weight trajectories and metabolic markers of diabetes in modernising China: which timescale is most relevant?Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study.Response to the Letter: Comment on "Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance" by Scheuer S.H., et al.
P50
Q28727506-6A249030-9709-4F9C-A501-E98ACE3760A4Q28728387-C881FA0E-EE0E-4835-B166-67942582F5EAQ28743139-2FDE8086-CBF7-4AD1-9243-532E31C7A289Q30420533-886FF94B-5770-4727-8249-6A4E059F0DABQ33610252-F044314E-F1E8-4452-9F30-3AEB1BDF16BDQ33769774-46C80A56-C4A8-4805-B6A5-BD73A27DE98AQ33837104-3F737D23-5CF2-4A1D-8F24-1D33AAE9B187Q33843643-9E2AC0A9-6613-4A7B-862B-3569416DF333Q33926890-D558E19D-50F6-444F-9ED8-537E4772B3BCQ34516146-302E31A1-1FA9-4AFB-814C-0207C6C10CF2Q34905329-CBF87212-51E3-4020-8B3C-C5BB6D754864Q35093473-68804D02-CA8A-4F9B-A8E0-9F25273BB327Q36201463-0797258A-0E5F-4FC8-9136-8FD09B4530DFQ36297200-C7093887-21B1-4F8D-B93E-AC310694F4F2Q37278088-82A6E7EB-ECF1-4F13-8D9B-DCE8D8642EEFQ37714314-524EEDCE-C588-4BA7-87B2-B5CF980621F2Q38171593-52F39898-080E-47C7-B24F-9231D2FF06C9Q38205374-14777FB3-1F17-4894-9720-ACD3A99479C2Q38422461-BB2973E3-45D7-4C13-B710-F1AC93BE5553Q38686327-F7C38173-3F3D-4F33-A370-BE3D3A91BAA9Q38737540-AC10C23A-049F-43E1-B001-9B1627E251BEQ39325486-40B6443C-D90E-4BF5-84E2-B1ADDE8BD8BCQ39601786-B3A89AB1-C98B-4A39-9742-6C2B0A20435CQ40098483-168DAFB9-62DF-4A23-B38E-E2BF708A473FQ40570455-6497E849-B1F1-4D66-BFAB-668514794A10Q40636102-54E08565-D764-4359-B486-E6B8903DC1C6Q40787024-20787C0E-2006-44D2-A732-C678AA0AD3A9Q41119709-91108ACF-84A5-4563-9F3C-34F732D95DC1Q41181012-307434AC-AF54-4F13-9C80-C1C9D31FE03AQ42419413-386E9B54-BC7F-48FC-8076-9ED8F19414B3Q42871368-92FA87F5-6D6E-4AEA-A169-188E8ED210C7Q42880211-BC00651F-2D6B-4342-8BF3-CF08A7838E15Q44268933-25AF2D54-E399-4E7E-BB0C-56BC55683003Q45497146-262060D9-A4F2-4C47-AB9A-CD2005821309Q46325495-9BFCCB53-D813-46C8-AC81-B006A941F142Q47219486-52F1F1F5-D733-4188-B32F-2F10CF3A7A4FQ47412036-69F7BAE8-2FD6-4286-9A4D-4C41162936D6Q47432942-604BC96F-06EA-4858-913D-3F69C3BE20ECQ49914972-02153EEA-3826-4217-91ED-7285391B8926Q50236139-B06FB490-AAA2-4DBB-A309-4D6EC8B935C0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kristine Færch
@ast
Kristine Færch
@en
Kristine Færch
@es
Kristine Færch
@nl
Kristine Færch
@sl
type
label
Kristine Færch
@ast
Kristine Færch
@en
Kristine Færch
@es
Kristine Færch
@nl
Kristine Færch
@sl
prefLabel
Kristine Færch
@ast
Kristine Færch
@en
Kristine Færch
@es
Kristine Færch
@nl
Kristine Færch
@sl
P106
P21
P31
P496
0000-0002-6127-0448